Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Quick take on Which Is Cheaper Index Funds Or Mutual Funds, focusing on fee comparisons and how cost differences impact overall performance.
22,925 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Webull (Bull) 2025 earnings offer a window into user growth, revenue mix, and paths to profitability. This guide brea...
A top executive leaves Bitcoin Depot as regulators tighten the screws on crypto kiosks. The move highlights how the c...
Nvidia dominates AI GPUs, but Broadcom could offer a different path into AI growth. This article lays out three concr...
When margins rebound in the energy sector, even senior executives may trim holdings to align with evolving risk and o...
A Nurix Therapeutics insider recently sold shares, drawing attention from investors. This article breaks down the mov...
Anthropic’s spacex compute deal expands access to the Colossus supercomputer, boosting Claude capacity while triggeri...
An in-depth, easy-to-read analysis of Sezzle stock and its 2026 earnings trajectory. Learn the key metrics, growth dr...
Crypto traders are weighing ripple (xrp) solana (sol) as summer enters. The rivals push higher, but investors cite di...
A wave of AI compute demand is reshaping the chip landscape. While Cerebras eyes an IPO, the market shows that strong...
A provocative nickname sparked online chatter and real-world worries about policy and prices. This guide explains how...
Investors are weighing UnitedHealth Group as a 2026 contender. This guide breaks down the key drivers, risks, and a c...